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Abstract
Background: Prevention of infection due to multi-drug resistant organisms is particularly challenging because of
the spread of resistant bacteria beyond hospitals into the community, including nursing homes. This study aimed
to identify risk factors for the acquisition of a multidrug resistant (MDR) Escherichia coli in a local outbreak.
Methods: Study participants were all aged over 65 years. Cases had the MDR E. coli isolated from a routine urine
sample, and controls had a urine sample submitted to the laboratory in the same time period but the MDR E. coli
was not isolated. Information from clinical records was used to identify risk factors both in the hospital and the
community setting for acquisition of the MDR E. coli.
Results: 76 cases and 156 controls were identified and included in the study. In a multivariate analysis, risk factors
statistically significantly associated with acquisition of the MDR E. coli were female gender (adjusted OR 3.2; 95 %
confidence interval 1.5–6.9), level of care (high dependency OR 7.5; 2.2–25.7) compared with living independently),
and in hospital prescription of antimicrobials to which the MDR E. coli was resistant (OR 5.6; 2.5-12.9).
Conclusions: The major risk factors for the acquisition of a MDR E. coli were found to be residence in a nursing home
and in-hospital prescription of antimicrobials to which the MDR E. coli was resistant. This emphasises that prevention of
transmission of MDROs within a community needs to involve both hospitals and also other healthcare organizations, in
this case nursing homes.
Keywords: Drug resistance, Bacterial, Hospital, Nursing home, Risk factors, Antimicrobial prescribing, UTI,
Escherichia coli
Background
Urinary tract infections (UTIs) are the most common
bacterial infection in older populations [1]. Globally
there are an estimated 150 million UTIs each year lead-
ing to more than 6 billion dollars in direct healthcare
costs [2]. Although for most healthy adults UTIs are an
inconvenience requiring short-term antimicrobial ther-
apy, in patients with pyelonephritis including the elderly
this can lead to bacteremia, hospitalisation, systemic
antimicrobial therapy, decreased functional status and
death [3].
Multi-drug resistant organisms (MDRO) add further
complications which result in decreased effectiveness of
standard treatments [4]. The control of UTIs due to
MDROs can be challenging in particular due to the fre-
quent emergence of resistance to new antimicrobials
and the spread of resistant bacteria beyond hospitals into
the community including nursing homes [5]. These facil-
ities can act as reservoirs of these MDROs which can
then be transmitted to acute hospitals [5, 6]. In vulner-
able populations, including nursing home residents
where inappropriate treatment of asymptomatic bacter-
iurua may be a particular issue [7], UTIs can have higher
prevalence of resistance to antimicrobials including cip-
rofloxacin, cephazolin, and nitrofurantoin [8]. Mortality
is higher following bacteremia with strains resistant to
antimicrobials than with strains sensitive to antimicrobials
* Correspondence: patricia.priest@otago.ac.nz
2Department of Preventive and Social Medicine, University of Otago,
Dunedin, New Zealand
Full list of author information is available at the end of the article
© 2015 Ikram et al. This is an Open Access article distributed under the terms of the Creative Commons Attribution License
(http://creativecommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and reproduction in any medium,
provided the original work is properly credited. The Creative Commons Public Domain Dedication waiver (http://
creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
Ikram et al. BMC Infectious Diseases  (2015) 15:224 
DOI 10.1186/s12879-015-0974-0
[9], although this is most likely due to inappropriate em-
piric antimicrobial therapy rather than an association with
increased virulence of the E coli strains [10, 11].
Risk factors for diagnosis of UTIs caused by MDROs
can be classified as individual factors, predisposing fac-
tors, and bacterial factors [3]. Individual or demographic
characteristics that may affect risk of colonization of the
urinary tract with MDROs include older age [8, 12–14],
female sex [8], a history of UTIs [13, 15], and diagnoses
of dementia or poor functional level [5, 14], diabetes
[12, 13], and prostatic disease. Predisposing or healthcare-
associated factors associated with increased risk of
community acquired MDROs in the urinary tract in-
clude invasive procedures such as urinary catheterisa-
tion [13, 16], previous hospitalisation [12, 13, 15],
residence in a nursing home [8], and prior exposure to
antimicrobials [5, 12–19].
From 30 March 2009 to 30 June 2011 a phenotypically
distinct MDR Escherichia coli (E.coli), which failed to
ferment lactose on MacConkey agar and was resistant to
gentamicin, quinolones including fluoroquinolones, tri-
methoprim, trimethoprim-sulfamethoxazole, and amoxi-
cillin, and in this case susceptible only to nitrofurantoin
and cephalosporins, was identified as the cause of 77
UTIs in South Canterbury. This is a semi-rural region in
New Zealand, population 58,000. The first diagnosis of
this organism was in 2007, but in 2009 the prevalence of
fluoroquinolone resistance increased from 5 % E.coli iso-
lates in 2007 to a peak of 13 % resistance in 2009 and
2010 decreasing, after interventions to 9 % in 2011. In
2009 this necessitated a change in the antimicrobial for-
mulary to cover this MDR E. coli both for bacteraemia,
with the urinary tract as the potential source, and also
treatment for cystitis . Infection prevention and control
strategies were introduced with a view to decreasing the
transmission of this organism. These were; placing alerts
on the medical records and implementing infection pre-
vention and control precautions for cases with MDR
E.coli with this phenotype in both the acute hospital and
nursing homes, educating general practitioners with a
view to reducing fluoroquinolone use and education ses-
sions on infection prevention and control procedures for
the staff of the local nursing homes.
This study aimed to identify risk factors associated
with the acquisition of this MDR E. coli, to provide evi-
dence to support infection control and antimicrobial
stewardship strategies to reduce future transmission.
Methods
Study population and setting
We conducted a case-control study to investigate risk
factors for diagnosis of the UTI due to this MDR
E.coli in the South Canterbury region of New Zealand.
All cases and controls lived in this region, were 65 years
or older, and had submitted a urine sample for
microbiology.
Laboratory methods
Multidrug resistant E. coli was define as being resistant
to at least 3 classes of antimicrobial agent. In this case
the MDR E. coli was isolated by routine laboratory cul-
ture by plating 0.001 ml urine onto 5 % sheep blood agar
(BD Difco Fort Richard Auckland) and MacConkey agar
(BD Difco Fort Richard Auckland). This organism was
phenotypically distinct because it failed to ferment
lactose and was resistant to amoxicillin, trimethoprim,
norfloxacin, genatamicin and with variable susceptibility
to amoxicillin clavulanate. It remained susceptible to
nitrofurantoin and cephalosporins. It was not an ex-
tended β lactamase producer. Susceptibility to antimi-
crobials was performed using the Clinical Laboratory
Standard Institute (CLSI) disc method.
Molecular methods
Pulsed-field gel electrophoresis of XbaI- digested gen-
omic DNA was performed, at the ESR Porirua, as previ-
ously described [20]. PFGE banding patterns were
analysed using BioNumerics software version 6.6 (Ap-
plied Maths, St-Martens-Latem, Belgium), with the
Dice coefficient and unweighted- pair group method
with arithmetric averages, at settings of 0.5 % optimization
and 1.5 % position tolerance. Multilocus sequence typing
(MLST) was performed on isolates from 5 patients with
phenotypically characteristic features [21], sequence types
(ST) assigned, as described at http://mlst.warwick.ac.uk/
mlst/dbs/dbs/Ecoli. Sequences were analysed using BioNu-
merics software version 6.6.
Selection of cases
The cases were all individuals in this region meeting the
age criteria with a urine sample from which the MDR E.
coli was isolated between March 2009 and June 2011.
Cases were selected retrospectively using urine results.
Selection of controls
Controls were chosen from the laboratory work sheet.
For each case 2 controls were selected, being the sam-
ples from patients aged over 65, where the MDR E. coli
was not isolated, before and after the case sample on the
work sheet list. This was not intended to match controls
to cases – it was a pragmatic way of obtaining a repre-
sentative sample of potential controls in a situation
where it was not possible to enumerate all eligible con-
trols and randomly select from the list. Those selected
as controls included those where another organism was
isolated as well as those where culture was negative. All
urines are from patients with suspected urinary tract
infection, or suspected colonisation preoperatively.
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Data collection
Structured data forms were used to record data from
laboratory microbiology, hospital admission records, and
from each individual’s General Practitioner (GP). The
following data were collected: demographic data,
whether the person lived in their own home or a
residential facility, the level of care received, and hos-
pitalizations, antimicrobial prescriptions, and UTI
diagnoses in the previous 12 months. Antimicrobial
prescriptions were identified as being during a
hospitalization (‘hospital prescriptions’) or not during
a hospitalization (‘GP prescriptions’ – this included
prescriptions by emergency and outpatient departments,
where no hospital admission ensued).
Statistical methods
Data were analysed using Stata Statistic 12 [22] Version
Release 12. College Station, TX: StataCorp LP; 2011. and
two-sided p-values of <0.05 were considered statistically
significant. Categorical variables were compared using
Chi-squared tests.
Logistic regression was used to assess the effect of
risk factors on MDR E.coli infection. All variables with
a p < 0.2 for the univariate relationship with the out-
come were considered for inclusion in the logistic re-
gression model. ‘Level of care’ (independent, assisted
care, high dependency care) was used as the measure
of physical frailty. Where level of care was missing, if
the person lived in their own home they were cate-
gorized as ‘independent’, and if they lived in a resi-
dential facility they were categorized as ‘assisted living’.
‘Recurrent UTI’ was defined as three or more UTIs in the
past 12 months. Antibiotic use was assessed both as a ‘yes/
no’ variable, and as number of courses in the 12 months
prior to the date of submission of the urine specimen. We
included prescription only of antimicrobials to which the
MDR E coli was resistant, since antimicrobials to which it
was sensitive would not be expected to increase the risk of
infection.
Ethical approval
This study was approved by the New Zealand Multi-region
Ethics Committee (MEC/12/EXP/007).
Results
Figure 1 shows the epidemic curve for the outbreak. The
5 MLST typed isolates were all E.coli ST 131. We ini-
tially identified 78 cases and 156 controls, but on review
of hospital notes found that two of the cases were youn-
ger than 65 years and therefore ineligible to be cases in
this study. Therefore the analysis includes data from 76
cases and 156 controls.
The characteristics of the cases and controls are
shown in Table 1. Compared with controls, cases were
more likely to be female, be older, live in a residential fa-
cility, have been admitted to a hospital in the past
12 months, be diabetic, have been catheterized in the
past 12 months, and to have had more UTIs in the past
12 months.
Table 2 shows antimicrobial prescriptions from all set-
tings, GP practices, and in hospital for both cases and
controls. Compared with controls, cases were overall
more likely to have had prescriptions of any antimicro-
bials and of antimicrobials to which the MDR E coli was
resistant. This pattern was driven by prescribing in
hospitals, and in contrast, in the GP setting about the
same proportion of cases and controls had been pre-
scribed any antimicrobials and antimicrobials to which
the MDR E coli was resistant.
The main logistic regression model included the risk
factors hospitalization, hospital prescription of ‘resistant’
antimicrobials, age, gender, diabetes, level of care, and
recurrent UTI. A second logistic regression was per-
formed that maximized the number of participants in-
cluded by excluding diabetes and recurrent UTI, which
both had more than 7 % missing values. Neither model
included GP antimicrobial prescriptions, as they were
not different between cases and controls, or a history of
catheterisation, because 14 % of participants had missing
data on this variable.
The results of the logistic regression modelling are
shown in Tables 3 and 4. The highest odds ratios were
for prescription in hospital of antibiotics to which the
organism is resistant, and requiring a high level of care
in the usual living situation. When the number of pre-
scriptions in hospital for ‘resistant’ antibiotics was in-
cluded in the model, the risk was highest in those with 3
or more prescriptions. Diabetes, recurrent UTI, and
female gender all had similar odds ratios of between 2
and 3, and other ORs did not change markedly when
diabetes and recurrent UTI were excluded from the
model (allowing the model to include the 34 people who
Fig. 1 Epidemic curve
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had missing values on one of those). Hospital admission
and age were not related to the risk of MDR E coli UTI
independently of the other risk factors. In a further
logistic regression model including only the 177 par-
ticipants with data on catheterisation, the OR for
catheterisation in the past year was 2.45 (95 % CI
1.0–5.9). ORs for other variables were not meaning-
fully different with catheterisation included or not in-
cluded in the model (data not shown).
Discussion
This case control study was performed to identify the
local risk factors for acquisition of this MDR E. coli with
a view to using the identified risk factors to target infec-
tion control and antimicrobial stewardship interventions
In this small community AMR is rarely encountered
however, with the emergence of MDROs worldwide and
increasing travel within countries as well as internation-
ally, the introduction of MDROs is an increasing risk to
Table 1 Characteristics of cases and controls
Cases Controls p*
(N = 76) (N = 156*)
n (%) n (%)
Gender <0.001
Male 16 (21) 75 (48)
Female 60 (78) 80 (51)
Missing 0 1 (1)
Age 0.005
65–74 14 (18) 52 (33)
75–84 29 (38) 65 (42)
85+ 33 (43) 37 (24)
Missing 0 2 (1)
Residence <0.001
Own home 22 (29) 109 (70)
Residential facility 53 (70) 47 (30)
Missing 1 (1) 0
Level of care <0.001
Independent 25 (32) 104 (67)
Assisted living 38 (50) 46 (30)
High Dependency 12 (16) 6 (4)
Missing 1 (1) 0
Admitted to hospital in past year 0.01
Yes 54 (71) 84 (54)
No 21 (28) 71 (46)
Missing 1 (1) 1 (1)
Diabetes 0.014
Yes 23 (30) 26 (17)
No diabetes diagnosis 46 (61) 117 (75)
Missing 7 (9) 13 (8)
Catheterized in past year <0.001
Yes 29 (38) 23 (15)
No 38 (50) 109 (70)
Missing 9 (12) 24 (15)
Number of UTIs in past year <0.001
None 0 (0) 77 (49)
1 23 (30) 26 (17)
2 25 (33) 15 (10)
3+ 26 (34) 23 (15)
Missing 2 (3) 15 (10)
* p value for Chi squared test calculated excluding missing values







n (%) n (%)
Prescribed in any setting
Any antimicrobial prescriptions 68 (89) 111 (71) <0.001
Any ‘resistant’ 57 (75) 80 (51) 0.019
GP prescriptions
Any antimicrobial prescriptions 44 (58) 85 (54) 0.624
Any ‘resistant’ 30 (39) 62 (40) 0.919
Cephalosporins 5 (7) 7 (5)
Macrolides 6 (8) 11 (7)
Nitrofurantoin 10 (13) 9 (6)
Penicillins 17 (22) 51 (33)
Amoxicillin 9 (12) 20 (13)
Quinolones 16 (21) 27 (17)
Tetracyclines 4 (5) 11 (7)
Trimethoprimb 18 (24) 29 (19)
Hospital prescriptionsc N = 54 N = 84
Any antimicrobial prescriptions 45 (83) 52 (62) 0.007
Any ‘resistant’ 38 (70) 28 (33) <0.001
Gentamicin 11 (20) 7 (8)
Cephalosporins 13 (24) 26 (31)
Macrolides 6 (11) 14 (17)
Nitrofurantoin 7 (13) 3 (4)
Penicillins 25 (46) 18 (21)
Amoxicillin 7 (13) 5 (6)
Quinolones 26 (48) 18 (21)
Tetracyclines 3 (6) 1 (1)
Trimethoprimb 12 (22) 8 (10)
a ‘Resistant’ = antimicrobials to which the MDR E coli was resistant, i.e. gentamicin,
quinolones, trimethoprim, trimethoprim-sulfamethoxazole, and amoxicillin
b Trimethoprim or trimethoprim-sulfamethoxazole
c Among participants who had been hospitalized
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any geographical area [23]. Control of such outbreaks
with antimicrobial stewardship and infection prevention
and control are important strategies to slow the emer-
gence of MDROs at a local, national and global level. In
current healthcare environments this needs to be ac-
complished with minimal utilization of resources.
E.coli ST 131 is most commonly associated with com-
munity acquired infection [24], although more recently an
association with healthcare and elderly patients has been
described [25]. This association is mirrored in the out-
break setting in this study. The antimicrobial susceptibility
of E. coli has been shown to vary geographically and this
may be associated with residence in nursing homes [26].
Major findings
This case-control study found individual and predispos-
ing risk factors that were associated with the outbreak.
Individual risk factors that showed an association with
the MDR E. coli UTI included being female, having dia-
betes, having recurrent UTIs and requiring a higher level
of care all of which have been described in previous
studies [5, 8, 12–15]. The odds ratios associated with fe-
male gender, diabetes, recurrent UTIs, and age over 85
were around 2 to 3 in all analyses. Catheterisation in-
creased the risk to a similar degree, but predisposing
Table 3 Adjusted model of risk factors for MDR E coli infection,
antibiotics as yes/no variable
OR 95 % CI
Full model (N = 192)
Prescription of resistanta antibiotics in hospital 4.4 1.8–11.2
Level of care
Independent 1.0
Assisted living 2.3 1.1–4.9
High dependency 10.2 2.5–42.5
Hospital admission 1.0 0.4–2.5
Recurrent UTI 2.2 1.0–4.9
Diabetes 2.4 1.0–5.7





Excluding diabetes and recurrent UTI (N = 226)
Prescription of resistanta antibiotics in hospital 5.6 2.5–12.9
Level of care
Independent 1.0
Assisted living 2.3 1.1–4.9
High dependency 7.5 2.2–25.7
Hospital admission 1.1 0.5–2.5





a ‘Resistant’ = antimicrobials to which the MDR E coli was resistant, i.e. gentamicin,
quinolones, trimethoprim, trimethoprim-sulfamethoxazole, and amoxicillin
Table 4 Adjusted model of risk factors for MDR E coli infection,
antibiotics as number of courses
OR 95 % CI
Full model (N = 192)







Assisted living 2.6 1.1–6.2
High dependency 9.4 2.3–38.7
Hospital admission 1.2 0.5–2.9
Recurrent UTI 2.1 0.9–4.7
Diabetes 2.6 1.1–6.1





Excluding diabetes and recurrent UTI (N = 226)







Assisted living 2.1 1.0–4.4
High dependency 6.9 2.0–23.2
Hospital admission 1.3 0.6–2.8





a ‘Resistant’ = antimicrobials to which the MDR E coli was resistant, i.e. gentamicin,
quinolones, trimethoprim, trimethoprim-sulfamethoxazole, and amoxicillin
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factors with much higher ORs were high dependency
care and prescriptions of antimicrobials to which the




In case control studies, controls should be selected from
the source population independently of their exposure
status. Case control studies of antimicrobial resistant in-
fections that use people infected with sensitive organ-
isms as controls [12, 14–19] give biased measurements
of the risk associated with antimicrobial prescription.
This is because people who were infected with sensitive
organisms but received antimicrobials before specimens
were obtained, will no longer have sensitive organisms
in their specimen and will not be eligible as controls, so
the prevalence of prior antimicrobial use in controls will
be artificially low [27]. In this study, both cases and con-
trols come from a community-based population of indi-
viduals who required a urine test, so controls should
represent the same population that gave rise to the
cases.
Limitations
Typing was performed on 5 isolates to investigate this
phenotypically distinct MDR E.coli emerging in a popu-
lation with otherwise low rates of MDR. They were all
the same MLST type; E.coli ST 131, and further typing
was not performed in this clinical context. Typing of
more than the 5 isolates may have confirmed a clonal
outbreak.
Although the sample provided sufficient power to find
statistically significant associations of a number of risk
factors, the confidence intervals are generally fairly wide.
A larger study would be necessary to obtain more pre-
cise estimates of the importance of catheterisation, dia-
betes and recurrent UTI for the risk of this infection,
but the additional information would not affect our find-
ings that antimicrobial prescription in hospital, and level
of care are the strongest risk factors. Because the control
selection process meant that cases and controls’ speci-
mens had been submitted at similar times, we could not
assess whether there was an effect of the interventions
that were put in place in June 2010, on the risk of infec-
tion with the MDR E. coli.
Implications
Most of the risk factors identified in this study are not
modifiable as part of a strategy to prevent resistant
UTIs. It is not clear why female gender would increase
the risk of a resistant UTI in a population of people who
all had some reason for providing a urine specimen, un-
less perhaps the number of men in the control group
was inflated by men with prostatism whose doctors
wanted to exclude a UTI. The other risk factors are re-
flective of frailty, poor health, and dependence on others
for personal care.
An increased risk of resistant UTI may reflect selec-
tion of resistant organisms (through previous antibiotic
use), or transmission of resistant organisms from others.
We were not able to assess whether the antibiotics
prescribed in hospital were all necessary, but this study
supports the importance of the prudent use of antimi-
crobials in minimizing the risk of resistant infection.
Care of dependent elderly people in nursing homes may
be a factor in transmission, and underlines the import-
ance of infection control measures, including hand hy-
giene in this setting. Also, although hospitalization per
se did not have an effect on infection independent of
antibiotic prescriptions in hospital, only hospital and not
community prescriptions increased the risk of the MDR
E. coli UTI. This suggests that there may be a compo-
nent of the hospital environment that is important, per-
haps the opportunities for transmission of resistant
organisms afforded by the care of dependent elderly
people in hospital.
This study indicates the importance of multiple health-
care settings in the transmission of this MDR E. coli.
Local antimicrobial stewardship and infection prevention
and control strategies to control MDROs need to be
coordinated across multiple sectors to obtain optimal
outcomes [28]. While fluoroquinolone use in the com-
munity was not identified as a risk factor for this MDR
infection, it was an important component of the anti-
microbial stewardship and infection prevention and
control bundle which was associated with decreased
prevalence of this organism.
Conclusion
Antimicrobials should be used only as necessary in treat-
ing frail elderly people, and infection control strategies
such as hand and equipment hygiene are likely to be an
important component of their care in hospital and in the
community, to reduce the risk of future resistant UTIs.
The major findings of this study illustrate the importance
of all sectors of local healthcare on the transmission of
MDROs, and that focusing on a single setting will not give
maximal effect when implementing antimicrobial steward-
ship and infection prevention and control strategies to
slow the transmission of these organisms.
Competing interests
This work was supported by a grant from the Dunedin School of Medicine,
University of Otago, Dean’s Bequest Fund, and all authors declare that they
have no competing interests.
Authors’ contributions
RI conceived of the study, participated in the design of the study, collection
of data, and drafting and revision of the manuscript. RP participated in the
Ikram et al. BMC Infectious Diseases  (2015) 15:224 Page 6 of 7
design of the study, collection of data, preliminary statistical analysis, and
initial drafting of the manuscript. PP participated in the design of the study,
carried out the statistical analyses reported, and drafted, revised and finalised
the manuscript. AC participated in conception of the study and collection of
data. All authors read and approved the final manuscript.
Acknowledgements
Associate Professor Sheila Williams gave invaluable advice on the data analysis.
South Canterbury DHB and laboratory staff for assisting with data collection
and the isolation of the organisms.
Nosocomial Infections Laboratory, ESR, Porirua, for strain typing.
Author details
1Microbiology, Christchurch School of Medicine University of Otago,
Christchurch, New Zealand. 2Department of Preventive and Social Medicine,
University of Otago, Dunedin, New Zealand.
Received: 28 April 2015 Accepted: 29 May 2015
References
1. Yoshikawa TT. Perspective: aging and infectious diseases: past, present, and
future. J Infect Dis. 1997;176(4):1053–7.
2. Stamm WE, Norrby SR. Urinary tract infections: disease panorama and
challenges. J Infect Dis. 2001;183(Supplement 1):S1–4.
3. Richards CL. Urinary tract infections in the frail elderly: issues for diagnosis,
treatment and prevention. Int Urol Nephrol. 2004;36(3):457–63.
4. Karlowsky JA, Jones ME, Thornsberry C, Critchley I, Kelly LJ, Sahm DF.
Prevalence of antimicrobial resistance among urinary tract pathogens
isolated from female outpatients across the US in 1999. Int J Antimicrob
Agents. 2001;18(2):121–7.
5. Wiener J, Quinn JP, Bradford PA, Goering RV, Nathan C, Bush K, et al.
Multiple antibiotic-resistant Klebsiella and Escherichia coli in nursing homes.
JAMA. 1999;281(6):517–23.
6. Ben-Ami R, Schwaber MJ, Navon-Venezia S, Schwartz D, Giladi M,
Chmelnitsky I, et al. Influx of extended-spectrum beta-lactamase-
producing enterobacteriaceae into the hospital. Clin Infect Dis.
2006;42(7):925–34.
7. Nicolle LE, Long-Term-Care-Committee S. Urinary tract infections in long-
term-care facilities. Infect Control Hosp Epidemiol. 2001;22(3):167–75.
8. Laupland K, Ross T, Pitout JDD, Church D, Gregson D. Community-onset
urinary tract infections: a population-based assessment. Infection.
2007;35(3):150–3.
9. Melzer M, Petersen I. Mortality following bacteraemic infection caused by
extended spectrum beta-lactamase (ESBL) producing E. coli compared to
non-ESBL producing E. coli. J Infect. 2007;55(3):254–9.
10. Cooke NM, Smith SG, Kelleher M, Rogers TR. Major differences exist in
frequencies of virulence factors and multidrug resistance between
community and nosocomial Escherichia coli bloodstream isolates. J Clin
Microbiol. 2010;48(4):1099–104.
11. Horcajada JP, Shaw E, Padilla B, Pintado V, Calbo E, Benito N, et al.
Healthcare-associated, community-acquired and hospital-acquired
bacteraemic urinary tract infections in hospitalized patients: a prospective
multicentre cohort study in the era of antimicrobial resistance. Clin Microbiol
Infect. 2013;19(10):962–8.
12. Colodner R, Rock W, Chazan B, Keller N, Guy N, Sakran W, et al. Risk factors
for the development of extended-spectrum beta-lactamase-producing
bacteria in nonhospitalized patients. Eur J Clin Microbiol Infect Dis.
2004;23(3):163–7.
13. Rodriguez-Bano J, Navarro MD, Romero L, Martinez-Martinez L, Muniain MA,
Perea EJ, et al. Epidemiology and clinical features of infections caused
by extended-spectrum beta-lactamase-producing Escherichia coli in
nonhospitalized patients. J Clin Microbiol. 2004;42(3):1089.
14. Eom JS, Hwang BY, Sohn JW, Kim WJ, Kim MJ, Park SC, et al. Clinical and
molecular epidemiology of quinolone-resistant Escherichia coli isolated from
urinary tract infection. Microb Drug Resist. 2002;8(3):227–34.
15. Colodner R, Kometiani I, Chazan B, Raz R. Risk factors for community-
acquired urinary tract infection due to quinolone-resistant E. coli. Infection.
2008;36(1):41–5.
16. Wu UI, Yang CS, Chen WC, Chen YC, Chang SC. Risk factors for bloodstream
infections due to extended-spectrum beta-lactamase-producing Escherichia
coli. J Microbiol Immunol Infect. 2010;43(4):310–6.
17. Hillier S, Roberts Z, Dunstan F, Butler C, Howard A, Palmer S. Prior antibiotics
and risk of antibiotic-resistant community-acquired urinary tract infection: a
case-control study. J Antimicrob Chemother. 2007;60(1):92–9.
18. Kuster SP, Hasse B, Huebner V, Bansal V, Zbinden R, Ruef C, et al. Risks
factors for infections with extended-spectrum beta-lactamase-producing
Escherichia coli and Klebsiella pneumoniae at a tertiary care university
hospital in Switzerland. Infection. 2010;38(1):33–40.
19. Steinke DT, Seaton RA, Phillips G, MacDonald TM, Davey PG. Prior
trimethoprim use and trimethoprim-resistant urinary tract infection: a nested
case-control study with multivariate analysis for other risk factors. J Antimicrob
Chemother. 2001;47(6):781–7.
20. Goering R. Pulsed-field electrophoresis. In: Persing DH, Tenover FC,
Versalovic J, Tang YW, Unger ER, Relman DA, White TJ, editors. Molecular
microbiology: diagnostic principles and practice. Washington: ASM Press;
2004. p. 185–96.
21. Foxman B, Zhang L, Koopman JS, Manning SD, Marrs CF. Choosing an
appropriate bacterial typing technique for epidemiologic studies. Epidemiol
Perspect Innov. 2005;2:10.
22. StataCorp. Stata statistical software. In: Release. 12th ed. College Station:
StataCorp LP; 2011.
23. Kuenzli E, Jaeger VK, Frei R, Neumayr A, DeCrom S, Haller S, et al. High
colonization rates of extended-spectrum beta-lactamase (ESBL)-producing
Escherichia coli in Swiss travellers to South Asia- a prospective observational
multicentre cohort study looking at epidemiology, microbiology and risk
factors. BMC Infect Dis. 2014;14:528.
24. Rogers BA, Doi Y. Who is leading this dance? Understanding the spread of
Escherichia coli sequence type 131. Infect Control Hosp Epidemiol.
2013;34(4):370–2.
25. Banerjee R, Johnston B, Lohse C, Porter SB, Clabots C, Johnson JR.
Escherichia coli sequence type 131 is a dominant, antimicrobial-resistant
clonal group associated with healthcare and elderly hosts. Infect Control
Hosp Epidemiol. 2013;34(4):361–9.
26. Galvin S, Bergin N, Hennessy R, Hanahoe B, Murphy AW, Cormican M, et al.
Exploratory spatial mapping of the occurrence of antimicrobial resistance in
E.coli in the community. Antibiotics. 2013;2:328–38.
27. Harris AD, Samore MH, Lipsitch M, Kaye KS, Perencevich E, Carmeli Y.
Control-group selection importance in studies of antimicrobial resistance:
examples applied to Pseudomonas aeruginosa, Enterococci, and Escherichia
coli. Clin Infect Dis. 2002;34(12):1558–63.
28. The Healthcare Infection Control Advisory Committee, Siegel JD, Rhinehart E,
Jackson M, Chiarello L. Management of multi-drug resistant organisms in
healthcare settings. Atlanta: CDC; 2006.
Submit your next manuscript to BioMed Central
and take full advantage of: 
• Convenient online submission
• Thorough peer review
• No space constraints or color ﬁgure charges
• Immediate publication on acceptance
• Inclusion in PubMed, CAS, Scopus and Google Scholar
• Research which is freely available for redistribution
Submit your manuscript at 
www.biomedcentral.com/submit
Ikram et al. BMC Infectious Diseases  (2015) 15:224 Page 7 of 7
